Science
Akhil Santhosh Highlights Neoadjuvant Immunotherapy for dMMR/MSI Gastroesophageal Adenocarcinoma
Akhil Santhosh/X

Akhil Santhosh Highlights Neoadjuvant Immunotherapy for dMMR/MSI Gastroesophageal Adenocarcinoma

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared on X:

“Neoadjuvant immunotherapy followed by surgery versus non-operative management in dMMR/MSI gastroesophageal adenocarcinomas: a case series and review of the literature – ESMO Gastrointestinal Oncology”

Authors: J.B. Demigné, F. Caillol, J. Guiramand, M. Heinisch, E. Mitry, B. Chanez, F. Benizri, B. Collineau, R. Mari, D. Dano, J.-E. Saadoun, and C. de la Fouchardière

Read the full article.

Akhil Santhosh

More posts featuring Akhil Santhosh.

Adenocarcinoma Akhil Santhosh B. Chanez B. Collineau C. de la Fouchardière cancer D. Dano E. Mitry F. Benizri F. Caillol gastroesophageal adenocarcinoma immunotherapy J. Guiramand J.-E. Saadoun J.B. Demigné M. Heinisch OncoDaily Oncology R. Mari